Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND-D: Daprodustat vs rhEPO in Dialysis Anemia
NCT02879305Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 35
01
Overview
A Phase 3 trial of daprodustat in anemia of chronic kidney disease (CKD-A), sponsored by GSK. Started Sep 2016; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02879305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02879305.